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Cav-p60, a specific and ubiquitous caveolar protein, was immunoprecipitated from solubilized rat adipocyte plasma membranes and identified
as similar to a GeneBank entry annotated mouse polymerase transcript release factor (PTRF) by MALDI-TOF and MS-MS of major fragments.
Cloning and virtual translation of the corresponding rat adipocyte cDNA sequence revealed 98.7% identity with mouse PTRF. In vitro translation
of this sequence produced a protein, which was recognized by antibodies to both cav-p60 and PTRF. EM gold labeling studies showed that a
rabbit antiserum against murine PTRF immunolabeled caveolae specifically in adipocytes from both mouse and rat. In view of the reported
function of the protein, which is exerted in the cell nucleus, its subcellular localization was investigated. We found that the protein could be
purified by differential solubilization of a plasma membrane fraction followed by SDS-PAGE, and that the protein was as abundant as caveolin in
this fraction. We were unable to detect the protein in cell nuclei by subcellular fractionation or fluorescence microscopy. The results show that in a
large number of cell types, PTRF is essentially located to caveolae, and that each caveola harbors many copies of the protein. Consequently, we
suggest the name Cavin for this protein.
D 2005 Elsevier B.V. All rights reserved.Keywords: Rat adipocyte; Caveolin; cav-p60; Electron microscopy; Polymerase and Transcript Release Factor; Mass spectrometry1. Introduction
The elusive biological significance of plasmalemmal caveo-
lae has been the inspiration for many recent studies. Unfortu-
nately, the intriguing morphology and distinct tissue
distribution of caveolae have given no immediate indication
of their function. The studies have therefore focused on
establishing their specific content of proteins and lipids. In
an early stage of this line of work, the caveolin proteins were
discovered as resident in caveolae and obligatory for their
presence [1–4]. Multiple information on the association of
caveolins with signaling proteins derives from the study of
detergent insoluble membrane fractions (rafts), but the mere
presence of proteins in this fraction does not prove that the
proteins interact in caveolae in the living cell [5]. Other
approaches are based on schemes of fractionation of cell0005-2736/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2005.09.013
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E-mail address: J.Vinten@mfi.ku.dk (J. Vinten).homogenates along with electron microscopic assessment of
subcellular localization [6,7]. Results solely based on cell
fractionation suffer from the inborn uncertainty of whether a
preparation is purely caveolar or in addition contains adjacent
membrane domains. At present, the most direct evidence for
the localization of a membrane protein to caveolae or to the
surrounding part of the membrane is obtained by immunoelec-
tron microscopy on the intact plasma membrane [7,8]. With
this direct approach, we have recently demonstrated the
presence of a previously undetected protein, cav-p60, on the
cytosolic face of caveolae utilizing a monoclonal antibody
(2F11) as reported [9]. In continuation, we have shown that
cav-p60 immunoreactivity is a general caveolar marker in a
broad range of cell types, and that cav-p60’s localization in
caveolae is independent of the prevailing caveolin isoform
[10]. The present work describes the identification of cav-p60
by immunopurification, peptide sequencing, cDNA cloning
and in vitro translation. Surprisingly, cav-p60 was identical to
the previously described polymerase 1 and transcript release
factor (PTRF) protein [11] which has also been named BBP forta 1717 (2005) 34 – 40
http://www
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binding protein [12]. The identity of cav-p60 and PTRF/BBP
was further ascertained by comparison of immunomicroscopi-
cal labeling patterns of 2F11 and a polyclonal antibody to
PTRF in a variety of rat tissues.
Our results are in line with the recent finding that PTRF
resides on the trypsin accessible face of a vesicular adipocyte
membrane preparation enriched in caveolin [13]. PTRF was
further shown to co-localize with caveolin in human adipocyte
plasma membranes [13] utilizing confocal microscopy on a
membrane preparation we developed for the study of the
membrane localization of cav-p60 by electron microscopy [9].
Since the designation cav-p60 now appears misleading for a
protein made up of 392 amino acid residues, we will use the
term cavin for cav-p60, PTRF or BBP in the following to
emphasize its specific localization.
2. Materials and methods
2.1. Immunopurification of cav-p60/cavin
Fat cells were isolated from epididymal fat pads of male Wistar rats by
collagenase digestion as previously described [8]. Fat cells were homogenized
in the presence of phenylmethylsulphonylfluoride (PMSF) and a plasma
membrane-enriched fraction was prepared by differential and gradient
ultracentrifugation according to [14]. The pelleted plasma membrane fraction
(approximately 200 Al) was solubilized in 1 ml of Tris-buffered saline (TBS),
pH 7.4 containing 1% w/v sodium dodecyl sulphate at room temperature and
centrifuged at 100,000g for 1 h. The supernatant was diluted to 10 ml with
TBS containing octylglycoside 80 mmol/l, and loaded slowly (20–25 min) on a
1-ml HiTrap protein G column (Amersham Pharmacia Biotech) preloaded with
100 Ag of the mouse monoclonal antibody 2F11. Upon washing with buffer
containing octylglycoside 75 mmol/l, antibody and complexes with antigen
were eluted with TBS containing 2% SDS and collected in 400 Al fractions.
Samples of load, run-through (including chase with 5 ml of washing buffer) and
SDS-eluate fractions were run on non-reducing 10% polyacrylamide gels in the
presence of SDS. The load sample was diluted 1.5-fold with washing buffer to
allow comparison with the chased run through fraction. Parallel gels, one with
application of 10 Al samples for immunoblotting with 2F11 and one with
application of 100 Al samples for staining with colloidal Coomassie blue from
Pierce, were run. Upon identification by means of the parallel immunoblot,
labeled with 2F11 and developed in the ECL system from Amersham, protein
bands in lanes with high protein load were excised and saved. The remains of
this gel was immunoblotted in order to verify that the excised band
corresponded to the immunoreactive protein (not shown). The gel piece was
digested with trypsin and the released peptides were analyzed by mass
spectrometry.
2.2. Protein identification by mass spectrometry
The protein was identified as described previously [15]. In short, the
relevant band was excised from the polyacrylamide gel, reduced, alkylated
using iodoacetamide, and digested by trypsin. The resulting fragments were
extracted, purified using C18 ZipTip (Millipore) and measured by MALDI-
TOF mass spectrometry on a Biflex instrument (Bruker, Bremen). An aliquot of
2 Al of the purified peptide mixture was introduced into a Q-Tof-2 tandem mass
spectrometer (Micromass, Manchester, UK) using the nanospray interface and
analyzed in MS mode as well as in MSMS mode for a number of fragments to
obtain sequence information.
2.3. Cloning, sequencing and in vitro translation of rat cavin
Using the Marathon cDNA amplification kit from Clontech with primers
designed from the published mouse PTRF cDNA sequence [11], 5V and 3VRACE reactions were performed on an anchor ligated rat cDNA library
purchased from Clontech, and full-length cDNA obtained by amplification of
mixed, overlapping 5V and 3V products with primers corresponding to the
anchors. The full-length rat cDNAwas ligated into the TOPO-TA plasmid from
Invitrogen, cloned and sequenced in an ABI PRISM 310 sequencer. The
sequence was found identical in all positions to the predicted rat PTRF
sequence accessible in GenBank (gi)27689506).
Using the TNT T7 Quick Coupled Transcription/Translation System kit
from Promega, transcription and translation directed by the TOPO-TA plasmid
with an insert of nucleotides 1 to 903 of the rat cavin cDNA sequence was
performed. The reaction product was analyzed by immunoblotting with the
antibody 2F11. A plasmid with the same sequence in the reverse orientation
was used as negative control.
2.4. Differential solubilization of adipocyte plasma membranes
Adipocytes in a 50% (vol/vol) suspension in TBS containing 1% bovine
albumin were diluted 20 fold in ice cold, Tris-buffered, isotonic sucrose and
disrupted by suction through a 20 gauge, 5 mm long cannula with a pressure
gradient of approximately 1 bar. A plasma membrane-enriched fraction was
prepared from this homogenate by differential ultracentrifugation according to
the previously described method [14]. The plasma membrane fraction was
pelleted and extracted at 4 -C with 0.5% Triton X-100 in TBS. The amounts of
protein in the plasma membrane fraction, extract and non-solubilized residue
were determined with the DC protein assay from Bio-Rad (cat. no. 500-0113).
Samples of the fractions were separated by SDS-PAGE and the gel stained with
either colloidal Coomassie blue (GELCODE Blue Stain from Pierce, cat. no.
24590) or classical Coomassie blue as detailed in, e.g., [16]. Prominent bands
excised from the lane loaded with non-solubilized residue were identified by
MALDI-TOF. By comparison of band patterns in lanes loaded with fractions
obtained as described above it was checked that the performance of the
colloidal Coomassie stain was similar to that of the classical Coomassie
stain.
2.5. Preparation of plasma membrane and nuclear fractions
Isolated fat cells were disrupted in an isotonic sucrose-containing Tris
buffer by gentle homogenization in a Potter Elvehjelm homogenizer with a
Teflon pestle (25 Am clearance). A plasma membrane and a nuclear fraction
were obtained by differential and gradient ultracentrifugations according to
[14]. The purity of the nuclear fraction was checked by phase contrast
microscopy. Fractions were analyzed by SDS-PAGE and immunoblotting,
using the monoclonal antibodies 2F11 and 6B6 towards cavin and caveolin-1,
respectively [9]. After stripping, blots were digested with alkaline phosphatase
(bovine intestinal alkaline phosphatase from Sigma, cat no. 5521) at 37 -C for
30 min and reprobed with 2F11. The effectiveness of phosphatase treatment
was confirmed by the disappearance of numerous bands apparent after staining
of parallel blots with an antibody to phosphoserine epitopes.
2.6. Specimens for immunogold-electron microscopy
Plasma membrane sheets with the cytosolic face exposed were prepared by
adsorption of adipocytes to a polylysine coated carbon layer, deposited on a
formvar film carried on an EM grid, followed by rupture of the cells by a jet of
buffer, as described earlier [8]. The adherent sheets of plasma membrane were
briefly fixed with 0.2% phosphate-buffered glutaraldehyde for 20 to 120 s and
blocked with bovine albumin. Indirect immunolabeling was done using the
monoclonal mouse 2F11 or a polyclonal rabbit antibody towards murine PTRF
kindly donated by I. Grummt, Heidelberg (17) as primary antibodies, and 8 nm
gold particles conjugated with affinity purified goat anti-mouse IgG (DAKO,
cat. no. Z420) or porcine anti-rabbit IgG (DAKO, cat. no. Z196), respectively.
The labeled specimens were negatively stained with sodium silicotungstate.
2.7. Specimens for fluorescence microscopy
Male Wistar rats were anesthetized with pentobarbital and fixed by
perfusion with 70% ethanol through a cannula inserted in the aorta through
Fig. 1. Immunoblot of fractions from immunopurification of cavin from
solubilized adipocyte plasma membranes with 2F11 as primary antibody.
Solubilized adipocyte plasma membranes before (lane 1) and after (lane 2)
immunosorption on a protein G column loaded with mab 2F11. Lane 3 is
column wash, 4 to 11 are 10-Al aliquots of 400 Al fractions collected during
elution with Tris buffer containing 2% SDS. From a parallel gel loaded with
100-Al aliquots gel pieces located as the framed bands were excised and used
for tryptic digestion and mass spectrometry.
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fat pad) were excised and placed in 96% ethanol, dehydrated further in absolute
ethanol, passed through xylene and finally infiltrated and embedded in paraffin.
De-paraffinized sections were blocked with 10% goat serum in TBS for 30 min
and incubated overnight at 4 -C with primary antibodies. Primary antibodies
were monoclonal 2F11 [9] or rabbit anti-PTRF [11]. Secondary antibodies were
goat anti-mouse 115-095-146 from Jackson Immunoresearch and porcine anti-
rabbit Z205 from DAKO, both labeled with fluoresceine.
3. Results
3.1. Immunopurification of cavin
Preliminary experiments showed that the immunoreactive
protein in a plasma membrane-enriched, subcellular fraction
from isolated rat fat cells was only partially soluble in non-
ionic detergents, but that it could be completely solubilized in
1% SDS. Immunoreactivity of the protein was, however,
reversibly lost in the presence of 1% SDS. Therefore, a plasmaFig. 2. Aligned sequences of rat, mouse and human PTRF/cavin. The 3 partial sequ
gave the primary identification of cavin. Other aa residues were determined by conmembrane-enriched fraction was solubilized with 1% SDS,
diluted ten fold in 80 mM octylglycoside and run through a
protein G column loaded with 2F11. Samples of load, run-
through and SDS-eluate fractions were run on non-reducing
10% polyacrylamide gels in the presence of SDS. Parallel gels,
one with application of 10 Al sample for immunoblotting with
2F11 and one with application of 100 Al samples for staining
with Coomassie blue, were run. Protein bands in lanes with
high protein load were identified by means of the parallel
immunoblot (see Fig. 1), excised and saved. The remains of
this gel was immunoblotted in order to verify that the excised
band corresponded to the immunoreactive protein (not shown).
The immunoreactive protein is referred to as cavin in the
following. The piece of gel containing cavin was digested with
trypsin and the digest analyzed by MALDI-TOF. The spectrum
of tryptic peptide fragments was compared to the patterns
predicted from the proteins in the SWISS-protein database, and
the best match was confirmed by MS–MS sequencing of three
fragments. This procedure identified cavin as PTRF, cf. Fig. 2.
The band identified by labeling with 2F11 could also be
labeled with a commercial monoclonal antibody raised against
a peptide representing amino acid residues 157–272 of PTRF
(BD Biosciences cat. no. 611258, results not shown).
3.2. Cloning and sequencing of rat cavin
The rat cDNA corresponding to mouse PTRF was PCR-
amplified from an anchor ligated cDNA library from rat fat
cells using primers derived from the mouse PTRF sequence.
Upon cloning into a plasmid vector the rat cDNA sequence was
determined in both directions and found identical to the rat
PTRF sequence which had meanwhile become accessible in
GenBank. The deduced amino acid sequence of rat PTRF/
Cavin was 98.7% identical to the corresponding mouseences determined by MS–MS are shown in italics or bold and these sequences
ceptual translation of the cDNA sequence.
Fig. 3. Immunoblot of an in vitro translation reaction directed by the truncated
rat cavin sequence corresponding to nucleotides 1–903 (lane 1) and of the
reaction directed by the corresponding reverse sequence (lane 2). The primary
antibody was 2F11.
Fig. 5. Immunoblots of SDS-PAGE gels for assessment of recovery of caveolin
and cavin in fractions enriched in plasma membrane and nuclei. The primary
antibody against caveolin (blot A) was 6B6, and that against cavin was 2F11
(blot B). Lane 1 was loaded with 50 Ag of plasma membrane fraction protein
and lanes 2–7 with a 3-fold dilution series of this fraction as indicated. Lane
8 was loaded with 4 Ag of nuclear fraction protein.
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through the homepage of The National Center for Biological
Information. Fig. 2 shows the alignment of the rat PTRF/Cavin
sequence to the corresponding mouse and human sequences. It
appears from the alignment that the only non-conservative
differences between the rat and mouse sequences were located
in positions 28 and 198. As the monoclonal antibody 2F11 is
rat specific, its epitope can be assumed to be located near to
one of these positions. Furthermore, the fact that 2F11 also
does not cross-react with the human protein (data not shown)
and that the human sequence is identical to the rat sequence in
the region near position 198 indicates that the epitope for 2F11
cannot be located there and must consequently be located near
position 28.
3.3. In vitro translation of truncated rat cavin
Fig. 3 shows a Western blot of the translation products from
a combined in vitro transcription and translation reaction
directed by nucleotides 1–903 of the rat cavin cDNAFig. 4. Coomassie blue stained SDS-PAGE of differentially solubilized
adipocyte plasma membranes. Left lane: Fifteen Ag of protein from the Triton
X-100 insoluble fraction were applied; the indicated bands were identified by
mass spectrometry. Thirty-five Ag of protein from the Triton X-100 soluble
fraction were applied in the lane right of the MW standards, and in the
rightmost lane 50 Ag of protein from the unfractionated plasma membrane.sequence. The immunolabeled band appears with an apparent
Mw of about 50 kDa, which could be expected from the
apparent size of 60 kDa of the full translation product, cf.
Discussion. The band is absent in the lane representing the
product of a control reaction directed by the reverse rat cavin
cDNA sequence.Fig. 6. Electron micrograph of immunogold labeled adipocyte plasma
membrane sheets. (A) Labeling with 2F11 as primary antibody. (B) Labeling
with polyclonal rabbit antibody against PTRF. The labeling pattern is the same
and restricted to caveolae.
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Exploiting the poor solubility of cavin in non-ionic
detergents, its recovery among the Triton X-100 insoluble
proteins from the plasma membrane fraction was investigated.
Fig. 4 shows that the main part of cavin is insoluble in Triton
X-100, and that the band pattern of the insoluble fraction is
different from that of the plasma membranes. Also, caveolin is
highly enriched in the insoluble fraction. Coomassie blue
staining of the SDS-gel shows that the recovery of the protein
is about the same as the recovery of caveolin. Excision and
subsequent MALDI TOF and MS–MS analysis indicated that
the bands were not contaminated with other proteins.
3.5. Recovery in a nuclear fraction
Fat cell nuclei were prepared according to [14]. The purity
of the fraction was checked by phase contrast microscopy, and
no contaminating membrane vesicles or cell debris were
observed. The recovery of caveolin and cavin in the nuclear
fraction was compared by immunoblotting, see Fig. 5. Judged
from the intensity of immunolabeling of bands and dilution
factors, the recovery of cavin in the nuclear fraction did not
exceed that of caveolin and was about 3% of the recovery in
the plasma membrane fraction. Reprobing of the blot afterFig. 7. Indirect immunofluorescence micrographs of rat tongue (A, B), fat (C, D) and
frames B, D and F were labeled with rabbit polyclonal antibody against PTRF. The
exhibits labeling of the sarcolemma, capillaries and vascular smooth muscle. In adip
hepatocytes are unlabeled, only the vasculature of portal spaces is labeled.digestion with alkaline phosphatase did not alter the relative
recovery of immunoreactivity showing that the reactivity of the
antibodies was independent of phosphorylation of the cavin/
PTRF protein.
Immunogold labeling of fat cell plasma membranes sheets
labeled with the monoclonal antibody 2F11 as primary
antibody produced a distinct caveolar localization of the gold
particles (Fig. 6, panel a). An identical pattern of labeling was
obtained using a rabbit antiserum against PTRF as primary
antibody (panel b). Caveolae in corresponding specimens of
mouse fat cell membranes were readily labeled with the rabbit
antiserum against PTRF, but could not be labeled with 2F11
(data not shown). Thus, 2F11 is rat specific.
3.6. Fluorescence microscopy of rat tissues
To study the cellular localization of cavin in different cell
types, sections of perfusion fixed rat tongue, adipose tissue and
liver were labeled with antibodies towards murine PTRF or the
monoclonal antibody 2F11 to rat cavin as primary antibodies
followed by the appropriate fluorescent secondary antibodies.
Nuclei were located by examination of the specimens in phase
contrast. With the limited resolution of this method, individual
caveolae cannot be identified, but cells rich in caveolae as, e.g.,
striated and smooth muscle cells exhibit a distinct, seeminglyliver (E, F). Frames A, C and E were labeled with 2F11 as primary antibody and
labeling pattern is the same with the two antibodies. Skeletal muscle of tongue
ose tissue, the cytoplasmic rim of fat cells and vasculature are labeled. In liver
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Fig. 7. Adipocytes and endothelial cells were heavily labeled
corresponding to the cell outline, but the thinness of their
cytoplasm do not allow distinction between plasmalemmal and
cytoplasmic labeling. Liver cells were devoid of labeling, but
endothelial cells in portal and hepatic veins and in some
sinusoids were labeled as were endothelial cells in other
tissues. Cell nuclei were unlabeled in all tissues studied.
4. Discussion
The present results identify the sequence of an abundant
caveolar protein, cavin/cav-p60. The primary identification was
achieved by purification of the rat homologue of the protein
from rat fat cell plasma membranes by means of a specific
monoclonal antibody and subsequent mass spectrometric
analysis of the purified protein. Furthermore, the protein was
purified from rat fat cell plasma membranes by differential
detergent solubilization and SDS-gel electrophoresis and again
identified by mass spectrometric analysis. Surprisingly, the
same protein has previously been named PTRF for Polymerase
I and Transcript Release Factor due to its ability to induce
dissociation of paused ternary transcription complexes in
various in vitro assays [11]. The present identification was
confirmed by the demonstration of specific labeling of the in
vitro translated protein by the monoclonal antibody to cavin,
and by the finding that a rabbit antibody as well as a
commercial monoclonal antibody raised against the homolo-
gous, recombinant mouse protein, PTRF [16], labeled the
purified rat cavin in Western blots. The electrophoretic mobility
of the PTRF/cavin protein of 392 amino acid residues is
reduced, since it appears as a protein of about 60 kDa, cf. [9]
and, e.g., Fig. 4 in ref. [17]. Reduced electrophoretic mobility
can be due to protein glycosylation, but the post-translational
modifications reported for PTRF/cavin [13] are serine phos-
phorylations and N-terminal acetylation, which are not likely to
reduce electrophoretic mobility. Further, we have observed that
full-length, recombinant cavin produced in E. coli has the same
mobility as that of cavin isolated from rat adipocytes
(unpublished data). The reduced mobility might reflect a
special behavior of the protein towards SDS micelles.
The rabbit antibody to PTRF also labeled caveolae
specifically in immunogold electron microscopy and produced
a pattern fully compatible with caveolar labeling in fluores-
cence microscopy. Our present findings corroborate and extend
a recent report that the labeling by a commercial antibody to
PTRF colocalized with caveolin labeling in human adipocyte
plasma membranes by confocal fluorescence microscopy [13].
We have previously found that cavin is specifically located to
caveolae at the ultrastructural level [9], and to the plasma
membrane at the cellular level [10], and that cavin is
consistently expressed in parallel with caveolin, irrespectively
of the isoform of the latter [10,19].
At the level of light microscopy, the labeling for cavin is
confined to the plasma membrane, and no labeling of nuclei
was demonstrable in any of the cell types examined. In a
nuclear fraction from mature adipocytes the relative recoveryof cavin was equal to the recovery of caveolin, which was only
about 3% of the recovery in the plasma membrane fraction.
Based on the heavy and specific labeling of the cytosolic face
of caveolae which can be achieved with antibodies towards
cavin, we have previously argued that the protein was likely to
be a structural component of caveolae due to its presence in
many copies [9]. The present finding that both cavin and
caveolin are recovered in the detergent insoluble fraction from
adipocyte plasma membranes supports this notion. The relative
abundance of the two proteins in this fraction is, however,
difficult to estimate because caveolin has been reported not to
stain with Coomassie blue [18]. In our hands, caveolin did stain
with Coomassie blue, as judged from the fact that mass
spectrometric analysis of the excised band did not indicate the
presence of other proteins. The discrepancy with regard to
staining might possibly be due to differences in prior
preparative steps.
PTRF was originally identified in a two-hybrid screen for
molecules interacting with TTF-1 (transcription termination
factor 1) and found to facilitate the dissociation of ternary
complexes of pre-rRNA, Pol1 and TTF-1 [11,17]. Later, PTRF
has also been reported to interact with the binding factor of a
type 1 collagen promoter zinc-finger transcription factor and
assigned a role as a regulator of proa´2(I) collagen proximal
promoter activity and thereby also to be involved in polymer-
ase II reactions [12]. Lately, caveolae have been identified as a
site of targeting and post-translational modification by prote-
olysis of PTRF and other PEST-domain containing proteins,
and it was reported that the proteolytic fragments of cavin/
PTRF could be dissociated from a caveolar preparation in
contrast with the full-length protein [13]. The implication of
PTRF in nuclear transcriptional and regulatory functions is
intriguing. We found that only a minor fraction of the adipocyte
full-length cavin was recovered in the nuclear fraction and that
this was fully explicable by plasma membrane contamination.
This finding is in line with the finding of Naboulaich et al. [13]
of minor quantities of full-length PTRF in the nuclear fraction,
but does not preclude the possibility that fragments of cavin/
PTRF lacking epitopes for the antibodies could have regulatory
functions in the cell nucleus.
However, our observation that caveolae, cavin and caveolin
are absent in liver parenchymal cells is difficult to reconcile
with a fundamental transcriptional regulatory function of cavin/
PTRF. Lack of expression of cavin/PTRF mRNA in liver cells
has earlier been reported [12].
Our present and earlier [9] results show that cavin is a major
caveolar resident, with a representation similar to that of
caveolin. Cavin and caveolin were shown to colocalize in
caveolae at the ultrastructural level [9]. In relation to our
previous suggestion of cavin as a structural protein of caveolae
[9], it is noteworthy that cavin lacks membrane spanning
domains and a caveolin binding motif to account for its affinity
to caveolae. A sequence homology search on the web site
http://www.ncbi.nlm.nih.gov/ showed that cavin has a 20%
sequence identity and 44% sequence similarity in the region
from aa residues 60–338 with myosin heavy chain, and that
there were 47% and 63% identity between two stretches of
J. Vinten et al. / Biochimica et Biophysica Acta 1717 (2005) 34–4040cavin (aa residue nos. 76–153 and 276–296, respectively) and
a phosphatidylserine binding protein isolated from blood
platelets [20]. As the caveolin scaffolding domain has recently
been shown to induce the formation of lipid domains enriched
in phosphatidylserine [21], it could be suggested that an
affinity for phosphatidylserine promotes the association of
cavin to the caveolar structure.
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